2024 | APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024 | HEPATOLOGY INTERNATIONAL |
2024 | Reduced Risk of Severe Radiation-Induced Lymphopenia in Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer: A Comparative Analysis of Carbon Versus Photon Therapy | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2024 | Combined High-Dose Radiotherapy with Sequential Gemcitabine-Cisplatin Based Chemotherapy Increase the Resectability and Survival in Locally Advanced Unresectable Intrahepatic Cholangiocarcinoma: A Multi-institutional Cohort Study
| CANCER RESEARCH AND TREATMENT |
2024 | Liver-Directed Combined Radiation Therapy for Downstaging Beyond-Milan Hepatocellular Carcinoma to Liver Transplantation | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2024 | Efficacy of stereotactic ablative radiotherapy in patients with oligometastatic hepatocellular carcinoma: A phase II study | JOURNAL OF HEPATOLOGY |
2024 | Defining Minimum Treatment Parameters of Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma: An Expert Consensus | PRACTICAL RADIATION ONCOLOGY |
2024 | Evaluation of the deliverability of dynamic conformal arc therapy (DCAT) by gantry wobble and its influence on dose
| SCIENTIFIC REPORTS |
2024 | Risk Factors for Distant Metastasis in Extrahepatic Bile Duct Cancer after Curative Resection (KROG 1814)
| CANCER RESEARCH AND TREATMENT |
2024 | Risk Stratification of Pancreatic Ductal Adenocarcinoma Patients Undergoing Curative-Intent Surgery after Neoadjuvant Therapy
| CANCER RESEARCH AND TREATMENT |
2023 | Efficacy of Radiomics in Predicting Oncologic Outcome of Liver-Directed Combined Radiotherapy in Locally Advanced Hepatocellular Carcinoma
| CANCERS |
2023 | Carbon Ion Radiotherapy in the Treatment of Hepatocellular Carcinoma
| CLINICAL AND MOLECULAR HEPATOLOGY |
2023 | Efficacy of Local Treatment in Lymph Node Metastasis from Hepatocellular Carcinoma | LIVER CANCER |
2023 | Efficacy of Liver-Directed Combined Radiotherapy in Locally Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
| CANCERS |
2023 | Vertebral compression fracture after stereotactic ablative radiotherapy in patients with oligometastatic bone lesions from hepatocellular carcinoma
| CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY |
2023 | Favorable response of hepatocellular carcinoma with portal vein tumor thrombosis after radiotherapy combined with atezolizumab plus bevacizumab
| Journal of Liver Cancer(대한간암학회지) |
2023 | Comparison of radiofrequency ablation and ablative external radiotherapy for the treatment of intrahepatic malignancies: A hybrid meta-analysis
| JHEP REPORTS |
2023 | The best indication for particle therapy in hepatocellular carcinoma
| International Journal of Gastrointestinal Intervention |
2022 | Stereotactic Ablative Radiotherapy for Oligometastatic Hepatocellular Carcinoma: A Multi-Institutional Retrospective Study (KROG 20-04)
| CANCERS |
2022 | Stereotactic body radiation therapy and radiofrequency ablation in patients with hepatocellular carcinoma: not a rival but a partner for the cure
| HEPATOBILIARY SURGERY AND NUTRITION |
2022 | Does HCC Etiology Impact the Efficacy of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma? An Asian Liver Radiation Therapy Group Study
| JOURNAL OF HEPATOCELLULAR CARCINOMA |
2022 | Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
| CANCER BIOLOGY & MEDICINE |
2022 | Biomarkers for Locally Advanced Hepatocellular Carcinoma Patients Treated with Liver-Directed Combined Radiotherapy
| LIVER CANCER |
2022 | Benefit of adjuvant radiotherapy for gallbladder cancer: a comparability-based meta-analysis | HEPATOLOGY INTERNATIONAL |
2022 | Stereotactic ablative radiotherapy for pulmonary oligometastases from primary hepatocellular carcinoma: a multicenter and retrospective analysis (KROG 17-08) | JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
2022 | Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
| CANCERS |
2022 | Skull Base Metastasis from Hepatocellular Carcinoma: Clinical Presentation and Efficacy of Radiotherapy
| JOURNAL OF HEPATOCELLULAR CARCINOMA |
2022 | Pattern and clinical significance of lymph node metastasis from hepatocellular carcinoma | JOURNAL OF CLINICAL ONCOLOGY |
2022 | Liver-directed concurrent chemoradiotherapy versus sorafenib in hepatocellular carcinoma with portal vein tumor thrombus | JOURNAL OF CLINICAL ONCOLOGY |
2022 | Early experience of combining immune checkpoint inhibitor and radiotherapy in heavily pretreated hepatobiliary cancer | JOURNAL OF CLINICAL ONCOLOGY |
2022 | The role of postoperative radiotherapy in hepatocellular carcinoma
| HEPATOBILIARY SURGERY AND NUTRITION |
2021 | Role of adjuvant radiotherapy in extrahepatic bile duct cancer: A multicenter retrospective study (Korean Radiation Oncology Group 18-14) | EUROPEAN JOURNAL OF CANCER |
2021 | Role of Interleukin-7 in the Development of and Recovery from Radiation-Induced Lymphopenia: A Post-hoc Analysis of a Prospective Cohort
| CANCER RESEARCH AND TREATMENT |
2021 | Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
2021 | Long-term survival after multimodal treatment involving radiotherapy for huge hepatocellular carcinoma with oligometastasis: a case report
| Journal of Liver Cancer(대한간암학회지) |
2021 | Curative liver transplantation after lung resection for advanced hepatocellular carcinoma with lung metastasis and inferior vena cava tumor thrombosis: a case report
| Journal of Liver Cancer(대한간암학회지) |
2021 | Adjuvant Radiotherapy for Extrahepatic Cholangiocarcinoma: A Quality Assessment-Based Meta-Analysis
| LIVER CANCER |
2021 | Efficacy of radiotherapy for gastric bleeding associated with advanced gastric cancer
| RADIATION ONCOLOGY |
2021 | Adjuvant radiotherapy and chemotherapy offer a recurrence and survival benefit in patients with resected perihilar cholangiocarcinoma | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
2021 | Improved oncologic outcomes by ablative radiotherapy in patients with bone metastasis from hepatocellular carcinoma | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
2021 | Combination therapy with anti-T-cell immunoglobulin and mucin-domain containing molecule 3 and radiation improves antitumor efficacy in murine hepatocellular carcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2021 | Optimal Timing of Radiotherapy after Incomplete Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma
| YONSEI MEDICAL JOURNAL |
2021 | Effect of Interleukin-7 on Radiation-Induced Lymphopenia and Its Antitumor Effects in a Mouse Model | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2021 | Radiotherapy as an immune checkpoint blockade combination strategy for hepatocellular carcinoma
| WORLD JOURNAL OF GASTROENTEROLOGY |
2021 | Efficacy of Local Therapy for Oligometastatic Hepatocellular Carcinoma: A Propensity Score Matched Analysis
| JOURNAL OF HEPATOCELLULAR CARCINOMA |
2021 | Dose-Response Relationship in Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: A Pooled Analysis of an Asian Liver Radiation Therapy Group Study | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2020 | Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion
| JOURNAL OF HEPATOCELLULAR CARCINOMA |
2020 | Liver-directed combined radiotherapy as a bridge to curative surgery in locally advanced hepatocellular carcinoma beyond the Milan criteria | RADIOTHERAPY AND ONCOLOGY |
2020 | Reply to: "Stereotactic body radiation therapy vs. radiofrequency ablation for HCC: More questions than answers | JOURNAL OF HEPATOLOGY |
2020 | Significance of lymphocyte recovery from treatment-related lymphopenia in locally advanced pancreatic cancer | RADIOTHERAPY AND ONCOLOGY |
2020 | Reply to: "Can sorafenib use influence outcome when comparing stereotactic body radiation therapy with radiofrequency ablation in patients with hepatocellular carcinoma?" | JOURNAL OF HEPATOLOGY |